This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Bio-Hpf Canada (2015-05-25)
- Starting date:
- May 25, 2015
- Posting date:
- May 26, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Natural health products
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-53539
Recalled Products
Bio-Hpf Canada
Reason
Lead exceeds the acceptable limit of 10 mcg/day as per quality of Natural Health Products Guide.
Depth of distribution
Distributors
Affected products
Bio-Hpf Canada
DIN, NPN, DIN-HIM
NPN 80048395
Dosage form
Capsule
Strength
- 5,6-Dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium chloride 40.0 mg
- Baptisia tinctoria 3.0 mg
- Bentonite 85.0 mg
- Berberis aquifolium 20.0 mg
- Berberis vulgaris 20.0 mg
- Commiphora myrrha 60.0 mg
- Deglycyrrhizinated licorice 100.0 mg
- Pimpinella anisum 20.0 mg
- Syzygium aromaticum 60.0 mg
- Ulmus rubra 80.0 mg
Lot or serial number
403082B
Companies
- Recalling Firm
-
NHP Consulting
1731 8th Ave NW
Calgary
T2N 1C5
Alberta
CANADA
- Marketing Authorization Holder
-
Biotics Research Corporation
6801 Biotics Research Dr
Rosenberg
77471
Texas
UNITED STATES